197 related articles for article (PubMed ID: 9559207)
1. Postliver transplant allograft reinfection with a lamivudine-resistant strain of hepatitis B virus: long-term follow-up.
Yoshida EM; Ma MM; Davis JE; Fischer KP; Kneteman NM; Erb SR; Tyrrell DL; Bain VG
Can J Gastroenterol; 1998 Mar; 12(2):125-9. PubMed ID: 9559207
[TBL] [Abstract][Full Text] [Related]
2. The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft loss.
de Man RA; Bartholomeusz AI; Niesters HG; Zondervan PE; Locarnini SA
J Hepatol; 1998 Oct; 29(4):669-75. PubMed ID: 9824278
[TBL] [Abstract][Full Text] [Related]
3. Antiviral combination therapy for lamivudine-resistant hepatitis B reinfection after liver transplantation.
Seehofer D; Rayes N; Neuhaus R; Berg T; Müller AR; Bechstein WO; Neuhaus P
Transpl Int; 2000; 13 Suppl 1():S359-62. PubMed ID: 11112032
[TBL] [Abstract][Full Text] [Related]
4. [Therapy of recurrent hepatitis B infection after liver transplantation. A retrospective analysis of 200 liver transplantations based on hepatitis B associated liver diseases].
Seehofer D; Rayes N; Bechstein WO; Naumann U; Neuhaus R; Berg T; Hopf U; Langrehr JM; Steinmüller T; Platz KP; Müller AR; Neuhaus P
Z Gastroenterol; 2000 Sep; 38(9):773-83. PubMed ID: 11072673
[TBL] [Abstract][Full Text] [Related]
5. Seroconversion after the addition of famciclovir therapy in a child with hepatitis B virus infection after liver transplantation who developed lamivudine resistance.
Shapira R; Daudi N; Klein A; Shouval D; Mor E; Tur-Kaspa R; Dinari G; Ben-Ari Z
Transplantation; 2002 Mar; 73(5):820-2. PubMed ID: 11907436
[TBL] [Abstract][Full Text] [Related]
6. Occurrence and clinical outcome of lamivudine-resistant hepatitis B infection after liver transplantation.
Seehofer D; Rayes N; Steinmüller T; Müller AR; Settmacher U; Neuhaus R; Radke C; Berg T; Hopf U; Neuhaus P
Liver Transpl; 2001 Nov; 7(11):976-82. PubMed ID: 11699034
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of famciclovir in the treatment of lamivudine resistance related to an atypical hepatitis B virus mutant.
Tang S; Ho SK; Moniri K; Lai KN; Chan TM
Transplantation; 2002 Jan; 73(1):148-51. PubMed ID: 11792996
[TBL] [Abstract][Full Text] [Related]
8. Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation.
Tillmann HL; Trautwein C; Bock T; Böker KH; Jäckel E; Glowienka M; Oldhafer K; Bruns I; Gauthier J; Condreay LD; Raab HR; Manns MP
Hepatology; 1999 Jul; 30(1):244-56. PubMed ID: 10385663
[TBL] [Abstract][Full Text] [Related]
9. Disappearance of hepatitis B virus core deletion mutants and successful combined kidney/liver transplantation in a patient treated with lamivudine.
Meisel H; Preikschat P; Reinke P; Hocher B; Budde K; Bechstein WO; Neuhaus P; Krüger DH; Neumayer HH
Transpl Int; 1999; 12(4):283-7. PubMed ID: 10460876
[TBL] [Abstract][Full Text] [Related]
10. Comparison of famciclovir and lamivudine in the long-term treatment of hepatitis B infection after liver transplantation.
Rayes N; Seehofer D; Hopf U; Neuhaus R; Naumann U; Bechstein WO; Neuhaus P
Transplantation; 2001 Jan; 71(1):96-101. PubMed ID: 11211203
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation.
Chan HL; Chui AK; Lau WY; Chan FK; Wong ML; Tse CH; Rao AR; Wong J; Sung JJ
J Med Virol; 2002 Oct; 68(2):182-7. PubMed ID: 12210406
[TBL] [Abstract][Full Text] [Related]
12. [Post-transplant prophylaxis of the recurrence of lamivudine-resistant YMDD mutant hepatitis B virus in liver recipients].
Yang Y; Yang Y; Zhang J; Yi HM; Lu MQ; Cai CJ; Li X; Jiang N; Xu C; Li H; Wang GS; Yi SH; Zhang JF; Jiang H; Yang Q; Chen GH
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1810-2. PubMed ID: 18971179
[TBL] [Abstract][Full Text] [Related]
13. Preoperative antiviral treatment and postoperative prophylaxis in HBV-DNA positive patients undergoing liver transplantation.
Seehofer D; Rayes N; Naumann U; Neuhaus R; Müller AR; Tullius SG; Berg T; Steinmüller T; Bechstein WO; Neuhaus P
Transplantation; 2001 Oct; 72(8):1381-5. PubMed ID: 11685107
[TBL] [Abstract][Full Text] [Related]
14. Detection of hepatitis B virus variants resistant to lamivudine and famciclovir among randomly selected chronic carriers from Spain.
León P; Pozo F; Echevarría JM
Enferm Infecc Microbiol Clin; 2004 Mar; 22(3):133-7. PubMed ID: 14987532
[TBL] [Abstract][Full Text] [Related]
15. Prophylaxis and treatment of hepatitis B virus reinfection following liver transplantation.
Zheng SS; Wu J; Liang TB; Wang WL; Huang DS; Xu X
Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):327-9. PubMed ID: 14607701
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of lamivudine in patients with hepatitis B virus precore mutant infection before and after liver transplantation.
Ben-Ari Z; Zemel R; Kazetsker A; Fraser G; Tur-Kaspa R
Am J Gastroenterol; 1999 Mar; 94(3):663-7. PubMed ID: 10086648
[TBL] [Abstract][Full Text] [Related]
17. Developing strategies for prevention and treatment of recurrent HBV in liver transplantation.
Nery JR; Weppler D; Lavandera R; Nery Avila C; Magill A; Rodriguez M; Reddy KR; Schiff E; Tzakis AG
Transplant Proc; 1999; 31(1-2):485-6. PubMed ID: 10083202
[No Abstract] [Full Text] [Related]
18. Selection of multiresistant hepatitis B virus during sequential nucleoside-analogue therapy.
Mutimer D; Pillay D; Cook P; Ratcliffe D; O'Donnell K; Dowling D; Shaw J; Elias E; Cane PA
J Infect Dis; 2000 Feb; 181(2):713-6. PubMed ID: 10669360
[TBL] [Abstract][Full Text] [Related]
19. Adefovir dipivoxil therapy in liver transplant recipients for recurrence of hepatitis B virus infection despite lamivudine plus hepatitis B immunoglobulin prophylaxis.
Akyildiz M; Karasu Z; Zeytunlu M; Aydin U; Ozacar T; Kilic M
J Gastroenterol Hepatol; 2007 Dec; 22(12):2130-4. PubMed ID: 18031370
[TBL] [Abstract][Full Text] [Related]
20. [Lamivudine as prophylaxis against hepatitis B virus reinfection following orthotopic liver transplantation].
Zheng S; Wu J; Wang W; Huang D; Liang T; Lu A
Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(7):445-8. PubMed ID: 12133511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
